Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Abeona Therapeutics Inc.

NASDAQ: ABEOHealthcare / Biotechnology / USA
7.96-0.2200-2.69%Vol 978 1141Y Perf -60.05%
Apr 18th, 2019 16:00
BID7.65 ASK8.04
Open8.20 Previous Close8.18
Pre-Market- After-Trading7.96
 - -%  - -%
Target Price
24.75 
Analyst Rating
Strong Buy 1.00
Potencial %
210.93 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)383 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
10.80 
Earnings Date
10th May 2019

Today's Price Range

7.908.40

 

52wk Range

6.2622.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
1.27%
3 Months
9.64%
6 Months
-14.78%
1 Year
-60.05%
3 Years
195.91%
5 Years
-64.62%

Name / TickerPriceChg.Chg.%
ABEO7.96-0.2200-2.69
AAPL203.860.73000.36
GOOG1 236.370.03000.00
MSFT123.371.60001.31
XOM81.13-0.3000-0.37
WFC47.580.03000.06
JNJ137.52-1.0000-0.72
FB178.28-0.5000-0.28
GE9.350.23002.52
JPM113.46-0.8400-0.73
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
4.20
Current Ratio
4.40
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-5 150.90
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-1 889.90
EBITDA Margin
-1 811.20
Pre-tax Profit Margin
-
Profit Margin
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
400
Revenue per Share
0.01
Revenue Growth 3 Years
37.48
Revenue Growth 5 Years
15.04

Earnings HistoryEstimateReportedSurprise %
Q04 2018-0.42-0.3614.29
Q03 2018-0.23-0.34-47.83
Q02 2018-0.16-0.25-56.25
Q01 2018-0.19-0.185.26
Q04 2017-0.13-0.19-46.15
Q03 2017-0.18-0.1327.78
Q02 2017-0.13-0.21-61.54
Q01 2017-0.13-0.130.00
Earnings Per EndEstimateRevision %Trend
3/2019 QR-0.31-29.17Negative
6/2019 QR-0.34-17.24Negative
12/2019 FY-1.47-9.70Negative
12/2020 FY-1.70-136.11Negative
Next Report Date10th May 2019
Estimated EPS Next Report-0.31
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume978 114
Shares Outstanding (in ths.)48 093
Trades Count3 537
Dollar Volume7 426 379
Avg. Volume395 067
Avg. Weekly Volume600 702
Avg. Monthly Volume380 765
Avg. Quarterly Volume400 929

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

47%53%

Bearish Bullish

46%54%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
8 (100.00 %)
8 (100.00 %)
8 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News